Beranda › PPOK › North Carolina
Uji klinis PPOK di North Carolina
22 studi untuk PPOK mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- dan 3 lainnya
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- Piedmont Healthcare - Family Medicine- Site Number : 8400022, Statesville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Carolina Research Center, Inc., Shelby
Menerima pesertaFase 2
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- dan 1 lainnya
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Menerima pesertaFase 4
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07053423A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
Menerima pesertaFase 2
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
Menerima pesertaFase 4
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- dan 1 lainnya
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of North Carolina Clinical Research Center, Chapel Hill
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
Menerima pesertaStudi observasional
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
Menerima pesertaFase 2/3
Usia 35 hingga 80 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07363694Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07031336STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
Menerima pesertaFase 3
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 hingga 55 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
Menerima peserta
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07051707Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06961214Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Feb 2026 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.